Cancer Care: New & Noteworthy

T cells attacking a cancer cell
The Future of Cancer: Five Reasons for Optimism

Learn about five hot science areas that are changing the way we understand and treat cancer.

T cells attacking a cancer cell
Three Days in the Life of Memorial Sloan Kettering
Three Days in the Life of Memorial Sloan Kettering

While you’re watching the three-part Cancer: The Emperor of All Maladies, here’s an idea of what we’re doing to care for our patients.

Three Days in the Life of Memorial Sloan Kettering
Pictured: Teresa Gilewski and filmmaker Barak Goodman
Considering the Human Side — and the History — of Cancer

MSK employees previewed the upcoming documentary Cancer: The Emperor of All Maladies, which features several of our scientists and their research.

Pictured: Teresa Gilewski and filmmaker Barak Goodman
Exceptional responders of new drugs in clinical trials.
What Are Exceptional Responders?

When a clinical trial of a new drug fails because most patients don’t respond, progress can still be made by analyzing the tumors of the rare patients who benefit.

Exceptional responders of new drugs in clinical trials.
Pictured: Charles Sawyers
The Evolution of a Lifesaving Drug: A Scientist Reflects

Physician-scientist Charles Sawyers played a pivotal role in the development of Gleevec, one of the first successful targeted drugs for cancer.

Pictured: Charles Sawyers
Pictured: Chau Dang
Making the Most of Your First Appointment with Your Oncologist

Meeting with your oncologist for the first time? Suzanne Carmody, Director of MSK’s Physician Referral Service, shares tips for getting the most from that appointment.

Pictured: Chau Dang
Surgeon Larissa Temple
New Survey Helps Doctors Better Assess Outcomes for Rectal Cancer Surgery

A new online survey aims to provide doctors with real-time information on their patients’ quality of life after rectal surgery.

Surgeon Larissa Temple
Peter Scardino, Chair of MSK’s Department of Surgery and a specialist in the treatment of prostate cancers.
Predicting the Future of Cancer Surgery

Peter Scardino, Chair of MSK’s Department of Surgery, gives his views on what lies ahead for the surgical treatment of cancer.

Peter Scardino, Chair of MSK’s Department of Surgery and a specialist in the treatment of prostate cancers.
NYC Chinatown
Straight Talk: Connecting with Patients in Their Own Languages

Services including a pilot program for remote simultaneous medical interpreting using UN-style headsets can help improve care for a growing number of patients.

NYC Chinatown
Oren Cahlon and Nancy Lee
Proton Therapy: A Better Way to Destroy Tumors and Spare Normal Tissue

Proton therapy uses charged particles to target tumors with precision while reducing the risk of treatment-related side effects.

Oren Cahlon and Nancy Lee